San Francisco, Oct. 29, 2016 – Recardio, announced that its scientific presentation on dutogliptin was accepted and will be presented by Darrell Nix, CSO, at the TCT conference in Washington.Read More
Recardio at BIO Investor Forum 2016 in San Francisco
San Francisco, Oct. 18, 2016 – Recardio presented its clinical regenerative therapy program for cardiovascular diseases at the international BIO Investor Forum 2016 in San Francisco.Read More
Recardio Raises $11 Million in Series A Financing
San Francisco, Aug. 30, 2016 — Recardio today announced that it has raised $11 million in an increased Series A Financing.Read More
Recardio Names Darrell Nix as Chief Scientific Officer
San Francisco, Mar. 08, 2016 – Recardio named Darrell Nix as Chief Scientific Officer.Read More
Recardio to Present at Biotech Showcase 2016 during JP Morgan
San Francisco, Jan. 08, 2016 — Recardio to present at Biotech Showcase 2016 on January 11, 2016 at 2:00 p.m. PST during JP Morgan in San Francisco.Read More